Terms: = Liver cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Diagnosis
23 results:
1. Hepatic Stellate Cell-Targeting Micelle Nanomedicine for Early diagnosis and Treatment of liver Fibrosis.
Wang L; Zhou J; Wang J; Wang X; Dong H; Zhao L; Wu J; Peng J
Adv Healthc Mater; 2024 May; 13(12):e2303710. PubMed ID: 38293743
[TBL] [Abstract] [Full Text] [Related]
2. Non-invasive detection and complementary diagnosis of liver metastases via chemokine receptor 4 imaging.
Yang H; Tan S; Qiao J; Xu Y; Gui Z; Meng Y; Dong B; Peng G; Ibhagui OY; Qian W; Lu J; Li Z; Wang G; Lai J; Yang L; Grossniklaus HE; Yang JJ
Cancer Gene Ther; 2022 Dec; 29(12):1827-1839. PubMed ID: 35145271
[TBL] [Abstract] [Full Text] [Related]
3. ERK1/2 Signaling Induces Upregulation of ANGPT2 and cxcr4 to Mediate liver Metastasis in Colon cancer.
Urosevic J; Blasco MT; Llorente A; Bellmunt A; Berenguer-Llergo A; Guiu M; Cañellas A; Fernandez E; Burkov I; Clapés M; Cartanà M; Figueras-Puig C; Batlle E; Nebreda AR; Gomis RR
Cancer Res; 2020 Nov; 80(21):4668-4680. PubMed ID: 32816905
[TBL] [Abstract] [Full Text] [Related]
4.
Vallejo-Armenta P; Santos-Cuevas C; Soto-Andonaegui J; Villanueva-Pérez RM; González-Díaz JI; García-Pérez FO; Arrellano-Zarate A; Luna-Gutiérrez M; Azorín-Vega E; Ocampo-García B; Ferro-Flores G
Contrast Media Mol Imaging; 2020; 2020():2525037. PubMed ID: 32410920
[TBL] [Abstract] [Full Text] [Related]
5. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal cancer Patients.
Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
[TBL] [Abstract] [Full Text] [Related]
7. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
Peta V; Zhu J; Lubman DM; Huguet S; Imbert-Bismutd F; Bolbach G; Clodic G; Matheron L; Ngo Y; Raluca P; Housset C; Rezai K; Poynard T;
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):681-691. PubMed ID: 31964615
[TBL] [Abstract] [Full Text] [Related]
8. A practical guide to laboratory investigations at diagnosis and follow up in Waldenström macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group.
Maqbool MG; Tam CS; Morison IM; Simpson D; Mollee P; Schneider H; Chan H; Juneja S; Harvey Y; Nath L; Hissaria P; Prince HM; Wordsworth H; Opat S; Talaulikar D
Pathology; 2020 Feb; 52(2):167-178. PubMed ID: 31902622
[TBL] [Abstract] [Full Text] [Related]
9. Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease.
Ravell JC; Matsuda-Lennikov M; Chauvin SD; Zou J; Biancalana M; Deeb SJ; Price S; Su HC; Notarangelo G; Jiang P; Morawski A; Kanellopoulou C; Binder K; Mukherjee R; Anibal JT; Sellers B; Zheng L; He T; George AB; Pittaluga S; Powers A; Kleiner DE; Kapuria D; Ghany M; Hunsberger S; Cohen JI; Uzel G; Bergerson J; Wolfe L; Toro C; Gahl W; Folio LR; Matthews H; Angelus P; Chinn IK; Orange JS; Trujillo-Vargas CM; Franco JL; Orrego-Arango J; Gutiérrez-Hincapié S; Patel NC; Raymond K; Patiroglu T; Unal E; Karakukcu M; Day AG; Mehta P; Masutani E; De Ravin SS; Malech HL; Altan-Bonnet G; Rao VK; Mann M; Lenardo MJ
J Clin Invest; 2020 Jan; 130(1):507-522. PubMed ID: 31714901
[TBL] [Abstract] [Full Text] [Related]
10. C-terminal-modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4.
Suzuki K; Ui T; Nagano A; Hino A; Arano Y
Sci Rep; 2019 Oct; 9(1):15284. PubMed ID: 31653903
[TBL] [Abstract] [Full Text] [Related]
11. Prospective non-invasive evaluation of cxcr4 expression for the diagnosis of MALT lymphoma using [
Haug AR; Leisser A; Wadsak W; Mitterhauser M; Pfaff S; Kropf S; Wester HJ; Hacker M; Hartenbach M; Kiesewetter-Wiederkehr B; Raderer M; Mayerhoefer ME
Theranostics; 2019; 9(12):3653-3658. PubMed ID: 31281504
[TBL] [Abstract] [Full Text] [Related]
12. Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era.
Hamid AA; Markt SC; Vicier C; McDermott K; Richardson P; Ho VT; Sweeney CJ
Clin Genitourin Cancer; 2019 Feb; 17(1):58-64.e1. PubMed ID: 30309761
[TBL] [Abstract] [Full Text] [Related]
13. Multi-parameter gene expression profiling of peripheral blood for early detection of hepatocellular carcinoma.
Xie H; Xue YQ; Liu P; Zhang PJ; Tian ST; Yang Z; Guo Z; Wang HM
World J Gastroenterol; 2018 Jan; 24(3):371-378. PubMed ID: 29391759
[TBL] [Abstract] [Full Text] [Related]
14.
Fang HY; Münch NS; Schottelius M; Ingermann J; Liu H; Schauer M; Stangl S; Multhoff G; Steiger K; Gerngroß C; Jesinghaus M; Weichert W; Kühl AA; Sepulveda AR; Wester HJ; Wang TC; Quante M
Clin Cancer Res; 2018 Mar; 24(5):1048-1061. PubMed ID: 29208671
[No Abstract] [Full Text] [Related]
15. Role of cxcr4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
[TBL] [Abstract] [Full Text] [Related]
16. Preparation and characterization of a new monoclonal antibody against cxcr4 using lentivirus vector.
Li X; Kuang Y; Huang X; Zou L; Huang L; Yang T; Li W; Yang Y
Int Immunopharmacol; 2016 Jul; 36():100-105. PubMed ID: 27124560
[TBL] [Abstract] [Full Text] [Related]
17. Oncogenic roles and drug target of cxcr4/CXCL12 axis in lung cancer and cancer stem cell.
Wang Z; Sun J; Feng Y; Tian X; Wang B; Zhou Y
Tumour Biol; 2016 Jul; 37(7):8515-28. PubMed ID: 27079871
[TBL] [Abstract] [Full Text] [Related]
18. Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.
Weinstock M; Aljawai Y; Morgan EA; Laubach J; Gannon M; Roccaro AM; Varga C; Mitsiades CS; Paba-Prada C; Schlossman R; Munshi N; Anderson KC; Richardson PP; Weller E; Ghobrial IM
Br J Haematol; 2015 Jun; 169(6):851-8. PubMed ID: 25833301
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of N-[(11)C]methyl-AMD3465 as a PET tracer for imaging of cxcr4 receptor expression in a C6 glioma tumor model.
Hartimath SV; van Waarde A; Dierckx RA; de Vries EF
Mol Pharm; 2014 Nov; 11(11):3810-7. PubMed ID: 25094028
[TBL] [Abstract] [Full Text] [Related]
20. Pathogenesis, diagnosis, and management of cholangiocarcinoma.
Rizvi S; Gores GJ
Gastroenterology; 2013 Dec; 145(6):1215-29. PubMed ID: 24140396
[TBL] [Abstract] [Full Text] [Related]
[Next]
